Are we ready for dual-site right atrial pacing?

Journal of the American College of Cardiology

Volumn 40, Issue 6, 2002, Pages 1151-1152

  Sami, Magdi ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART RHYTHM; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; MORBIDITY; MORTALITY; NOTE; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; SAFETY;

EID: 0037130745     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02110-1     Document Type: Editorial

References (10)

1. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
2. Affirm study - Oral communication late-breaking trials
3. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating anriarrhythmic therapy: A multicenter, double-blind, crossover study of fiecainide and placebo with transtelephonic monitoring
4. Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter
5. Amiodarone to prevent atrial fibrillation
6. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation
7. Prevention of recurrent atrial fibrillation with chronic dual site right atrial pacing
8. Atrial rachyarrhythmias associated with high degree interatrial conduction block: Prevention by permanent atrial resynchronization
9. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy
10. Design and implementation of the dual site atrial pacing to prevent atrial fibrillation (DAPPAF) chnical trial